Can Ketamine Help Depression? What We Know and Don't

Can Ketamine Help My Depression? What We Know (and Don’t) for Young Adults And Beyond

‍

Ketamine has gained attention as a powerful new treatment for depression — particularly for people who feel like nothing else has worked. But for young adults and families navigating treatment-resistant depression (TRD), the question remains:

‍

Is ketamine treatment safe and effective for me?

The answer, like so much in medicine, is nuanced. While the early research is promising, especially for rapid symptom relief, it’s important to approach ketamine treatment with both hope and honesty about what we know — and what we don’t yet know — about its use in adolescents and young adults.

‍

What the Research Says About Ketamine for Young Adults

Large, long-term studies on ketamine for depression in adolescents are still limited. That said, several small studies, open-label trials, and case series have offered encouraging results.

• Rapid Reduction in Depressive Symptoms: Young adults treated with ketamine often experience a decrease in depressive symptoms within hours to days—not the weeks or months that traditional antidepressants may require.
  
  
• Anti-Suicidal Effects: A noteworthy double-blind randomized controlled trial (RCT) comparing IV ketamine to midazolam (a sedative) found that ketamine was significantly more effective in reducing suicidal thoughts and depressive symptoms in adolescents one week post-infusion.¹

‍

What Are the Safety Considerations in Ketamine Therapy?

Available research suggests that ketamine is generally safe when administered under clinical supervision — with monitoring for blood pressure, heart rate, and dissociative experiences that can arise during treatment. However, the data in adolescents and young adults is still evolving.

Key safety observations include:

• Transient Side Effects: Young patients may experience nausea, dizziness, or dissociation during or  shortly after treatment, though these usually resolve within hours.
  
  
• Low Addiction Risk in Clinical Settings: Although ketamine carries some potential for misuse recreationally, when administered in a structured, medically supervised setting without access to take-home doses, the risk of addiction is considered very low.
  
  
• Brain Development Concerns: Because the brain continues maturing through the mid-20s — especially in areas related to judgment, emotional regulation, and executive function — clinicians should remain cautious. Ketamine is considered when its potential benefits clearly outweigh any theoretical risks to neurodevelopment.
  
  
• Psychological Readiness: A crucial part of the evaluation process is assessing whether the adolescent is developmentally ready to engage with the full spectrum of emotions that may arise during treatment. Patients should be able to understand that their experience might include feelings of awe, calm, or euphoria—but also, at times, fear or disorientation. Clinicians help frame these possibilities in a supportive way, encouraging a curious, non-judgmental mindset. Dissociative or perceptual changes — such as altered sense of time and space — are common, but usually tolerable and tend to subside within two hours.
  
  

At Lumin Health, we emphasize comprehensive screening before considering ketamine or Spravato for young adults, assessing for medical history, substance use, mental health diagnoses, and family or therapeutic support.

‍

What Are the Research Gaps in Ketamine Treatment to Date?

Even as clinical experience grows, it’s important to recognize the limitations of current research:

• Small Sample Sizes: Many studies to date have involved relatively few participants, limiting broad conclusions.
  
  
• Lack of Long-Term Data: We need more information on the long-term effects of ketamine treatment in younger populations — both in terms of mental health outcomes and cognitive development.
  
  
• Not a Standalone Cure: Ketamine, including Spravato, is not a cure-all. It’s most effective when integrated into a comprehensive treatment plan that may include therapy, lifestyle interventions, and ongoing psychiatric care.
  
  
• Limited Scope of Conditions: Most research to date has focused on treatment-resistant depression and suicidality. We still know little about ketamine’s effects in adolescents with other diagnoses (like bipolar disorder or PTSD) or with common comorbidities (such as anxiety, ADHD, or substance use).

Transparency with patients and families is essential. At Lumin Health, we are candid about these limitations while also sharing the positive clinical outcomes we’ve witnessed in practice.

‍

The Bottom Line: Balancing Hope and Caution with Ketamine for Mental Health 

So, can ketamine help your depression if you’re a young adult? The answer is a qualified yes, for some. The rapid relief ketamine can provide — especially in cases of suicidality or profound depression — makes it a compelling option when other treatments have failed.

But ketamine therapy is not a silver bullet. The best outcomes occur when ketamine treatment is used within a thoughtful, individualized treatment plan tailored to the young person’s needs, strengths, and support system.

If you or a young person you care about is grappling with treatment-resistant depression, we encourage you to seek a consultation. Together, we can explore whether ketamine or Spravato is a safe and appropriate step forward, grounded in the latest research and clinical best practices.

1. https://pubmed.ncbi.nlm.nih.gov/37414272/ (Accessed July 2025)